Exhibit 107
Calculation of Filing Fee Tables
Form S-8
Repare Therapeutics Inc.
Table 1 — Newly Registered Securities
| Security Type |
Security Title |
Fee Calculation Rule |
Amount Registered(1) |
Proposed Maximum Offering Price Per Unit |
Maximum Offering Price |
Fee Rate |
Amount of Registration Fee | |||||||||
| Fees to be Paid | Equity | Common shares, no par value per share, 2020 Equity Incentive Plan | Other(2) | 2,108,802(4) | $6.14 | $12,948,044.28 | 0.00014760 | $1,911.13 | ||||||||
| Fees to be Paid | Equity | Common shares, no par value per share, 2020 Employee Stock Purchase Plan | Other(3) | 421,760(5) | $5.219 | $2,201,165.44 | 0.00014760 | $324.89 | ||||||||
|
Fees Previously Paid |
— | — | — | — | — | — | — | — | ||||||||
| Total Offering Amounts | — | $15,149,209.72 | — | $2,236.02 | ||||||||||||
| Total Fees Previously Paid | — | — | — | — | ||||||||||||
| Total Fee Offsets | — | — | — | — | ||||||||||||
| Net Fee Due | — | — | — | $2,236.02 | ||||||||||||
| (1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional common shares, no par value (the “Common Shares”), of the Registrant that become issuable under the 2020 Equity Incentive Plan (the “2020 Plan”) and 2020 Employee Share Purchase Plan (the “ESPP”) by reason of any share dividend, share split, recapitalization or any other similar transaction that results in an increase in the number of the Registrant’s outstanding Common Shares. |
| (2) | Estimated in accordance with Rule 457(c) and (h) solely for the purpose of calculating the registration fee on the basis of the average of the high and low prices of the Registrant’s Common Shares as reported on the Nasdaq Global Select Market on February 21, 2024. |
| (3) | Estimated in accordance with Rule 457(c) and (h) solely for the purpose of calculating the registration fee on the basis of the average of the high and low prices of the Registrant’s Common Shares as reported on the Nasdaq Global Select Market on February 21, 2024, multiplied by 85%, which is the percentage of the price per share applicable to purchases under the ESPP. |
| (4) | Represents an automatic annual increase equal to 5% of the total number of Common Shares outstanding on December 31 of the preceding year, which annual increase is provided by the 2020 Plan. |
| (5) | Represents an automatic annual increase equal to 1% of the total number of Common Shares outstanding on December 31 of the preceding year, which annual increase is provided by the ESPP. |